Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation
Completed
Khon Kaen University
Phase 3
2004-12-01
The purpose of this study is to compare the efficacy on pupillary dilation between the single
dose versus the three doses of 1% tropicamide with 10% phenylephrine for complete ocular
examination.
CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography
Completed
Genentech, Inc.
Phase 1
2007-07-01
CNV from AMD is the leading cause of blindness in people over 50 in North America. The
hypothesis is to determine if there is an improvement in retinal function determined by ERG
following treatment with ranibizumab for AMD
CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography
Completed
Washington University School of Medicine
Phase 1
2007-07-01
CNV from AMD is the leading cause of blindness in people over 50 in North America. The
hypothesis is to determine if there is an improvement in retinal function determined by ERG
following treatment with ranibizumab for AMD
2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides
Completed
Khon Kaen University
Phase 4
2007-05-01
To compare the clinical efficacy and systemic side effects between 2.5% and 10% phenylephrine
for mydriasis in diabetic patient with darkly pigmented irides.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
